IL17A and metabolic dysfunction-associated steatotic liver disease: To define whether the increased hepatic IL-17RA expression and IL-17A and IL-17F production contributes to MCDD-driven NAFLD pathogenesis, WT, IL-17RA-/-, IL-17A-/- and IL-17F-/- mice were challenged with MCDD.